The SMN1 gene plays an important role in producing a protein needed for the health and function of motor neurons. Changes or loss of this gene are closely linked to spinal muscular atrophy, a genetic condition that affects voluntary muscle movement and strength. Understanding this connection helps explain how the condition develops.
Spinal muscular atrophy, commonly called SMA, is a genetic condition that affects the nerve cells responsible for controlling voluntary muscles. These muscles are involved in movements such as sitting, standing, walking, swallowing, and breathing. The condition is closely associated with changes in the SMN1 gene, which provides instructions for producing an important protein known as survival motor neuron protein. When the body does not produce enough functional SMN protein, motor neurons can gradually become damaged, leading to muscle weakness and reduced muscle movement.
The SMN1 gene is responsible for producing most of the survival motor neuron protein required for the normal maintenance and function of motor neurons. These specialized nerve cells are located in the brainstem and spinal cord and send signals from the nervous system to voluntary muscles. Healthy motor neurons depend on sufficient levels of SMN protein to function properly.
In many cases of spinal muscular atrophy, both copies of the SMN1 gene have a significant change or deletion. Because an individual typically inherits one copy of the gene from each parent, changes affecting both copies can greatly reduce the amount of functional SMN protein produced.
As motor neurons become affected, communication between the nervous system and muscles is reduced. Over time, this may result in muscle weakness, decreased muscle tone, and difficulty with certain physical movements. The age at which symptoms appear and their severity can vary among individuals with SMA.
Spinal muscular atrophy is generally inherited in an autosomal recessive pattern. This means that a person usually develops the condition after inheriting an altered or nonworking copy of the SMN1 gene from both parents. Individuals with one working copy and one altered copy are often described as carriers and may not experience symptoms of SMA.
Another gene called SMN2 can also influence the condition. The SMN2 gene produces a smaller amount of functional SMN protein and may partly compensate for the loss of normal SMN1 function. The number of SMN2 copies can vary between individuals, and this variation may contribute to differences in the severity and progression of SMA.
Understanding the relationship between the SMN1 gene and spinal muscular atrophy provides important insight into the genetic basis of the condition. Genetic evaluation can help identify relevant gene changes, assess carrier status, and support discussions with qualified healthcare and genetic professionals. Information about SMA and genetic testing is intended to support education and awareness and does not replace individualized medical advice, diagnosis, or care.